TrialThe oncologist2023

Anlotinib Combined With Toripalimab as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Prospective, Multicenter, Phase II Study.

Cheng-Sheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.